Researchers at Fox Chase Cancer Center, in collaboration with colleagues at Memorial Sloan-Kettering Cancer Center, have shown that an engineered antibody called DTA-1 led to rejection of 50 to 60 percent of tumors in a mouse model of melanoma. The antibody allows the immune system to overcome its natural reluctance to attack tumor cells.
How An Antibody Helps The Immune System Reject Cancer
April 27th, 2009 · No Comments
Tags: General
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment